| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AXON ENTERPRISE, INC. | Director | Common Stock | 19,162 | $4,905,286 | $255.99 | 27 May 2021 | Direct |
| CLOROX CO /DE/ | Director | Deferred Stock Units | 24,389 | $3,477,614 | $142.59 | 31 Dec 2021 | Direct |
| HERBALIFE LTD. | Director | Common Stock | 71,766 | $526,762 | $7.34 | 02 May 2025 | Direct |
| MCKESSON CORP | Director | Restricted Stock Units (RSUs) | 349 | $202,741 | $580.92 | 31 Jul 2024 | Direct |
| Better Therapeutics, Inc. | Director | Common Stock | 157,369 | $26,737 | $0.1699 | 18 Dec 2023 | Direct |
| Better Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 15,000 | 07 Jun 2023 | Direct |